469 related articles for article (PubMed ID: 32541513)
1. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.
Yao J; Gong X; Shi X; Fan S; Chen J; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20674. PubMed ID: 32541513
[TBL] [Abstract][Full Text] [Related]
2. Effect of febuxostat on blood pressure in hyperuricemic patients: A protocol for a systematic review and meta-analysis.
Yao J; Shi X; Fan S; Gao Y; Hu H; Wang P; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20673. PubMed ID: 32541512
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.
Yao J; Fan S; Shi X; Gong X; Zhao J; Fan G
PLoS One; 2021; 16(7):e0253492. PubMed ID: 34234365
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.
Batty JA; Tang M; Hall M; Ferrari R; Strauss MH; Hall AS
Syst Rev; 2018 Aug; 7(1):131. PubMed ID: 30144828
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
Zhang L; Zeng X; Fu P; Wu HM
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review.
Nochaiwong S; Ruengorn C; Mongkhon P; Thavorn K; Awiphan R; Noppakun K; Vongsanim S; Chongruksut W; Hutton B; Sood MM; Knoll GA;
Medicine (Baltimore); 2020 Apr; 99(17):e19767. PubMed ID: 32332616
[TBL] [Abstract][Full Text] [Related]
9. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.
Wang K; Hu J; Luo T; Wang Y; Yang S; Qing H; Cheng Q; Li Q
Kidney Blood Press Res; 2018; 43(3):768-779. PubMed ID: 29794446
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
Meza N; Pérez-Bracchiglione J; Pérez I; Carvajal C; Ortiz-Muñoz L; Olguín P; Rada G; Madrid E;
Medwave; 2021 Mar; 21(2):e8105. PubMed ID: 33830976
[TBL] [Abstract][Full Text] [Related]
11. The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
Xie Q; Tang S; Li Y
Ann Palliat Med; 2022 Apr; 11(4):1253-1263. PubMed ID: 34775774
[TBL] [Abstract][Full Text] [Related]
12. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
Ohtsubo T; Shibata R; Kai H; Okamoto R; Kumagai E; Kawano H; Fujiwara A; Kitazono T; Murohara T; Arima H
Hypertens Res; 2019 May; 42(5):641-649. PubMed ID: 30948834
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids for viral acute respiratory tract infections: protocol for a systematic review and meta-analysis of randomised controlled trials.
Yao J; Zhao J; Wang X; Yang Z; Lin Y; Sun L; Zhang Y; Lu Q; Fan G
BMJ Open; 2022 Sep; 12(9):e056919. PubMed ID: 36123053
[TBL] [Abstract][Full Text] [Related]
16. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
[TBL] [Abstract][Full Text] [Related]
17. Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Zaragoza-Macias E; Zaidi AN; Dendukuri N; Marelli A
J Am Coll Cardiol; 2019 Apr; 73(12):1564-1578. PubMed ID: 30121238
[TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
[TBL] [Abstract][Full Text] [Related]
19. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
[TBL] [Abstract][Full Text] [Related]
20. Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension.
Gnanenthiran SR; Borghi C; Burger D; Charchar F; Poulter NR; Schlaich MP; Steckelings UM; Stergiou G; Tomaszewski M; Unger T; Wainford RD; Williams B; Rodgers A; Schutte AE
BMJ Open; 2021 Feb; 11(2):e043625. PubMed ID: 33593784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
